iTeos Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-09. The offering totals $125.4M, of which $125.4M was reported sold. Industry: Other Technology.
| Name | Role | Location |
|---|---|---|
| Priyanka Belawat | Director | Cambridge, MA |
| Detlev Biniszkiewicz | Director | Cambridge, MA |
| Chris Buyse | Director | Victoria, A1 |
| Michel Detheux | Director | Cambridge, MA |
| Ansbert Gadicke | Director | Morristown, NJ |
| David Hallal | Director | Cambridge, MA |
| Jonathan Skipper | Director | Cambridge, MA |
| Tim Van Hauwermeiren | Director | Cambridge, MA |
| Michel Detheux | Executive Officer | Cambridge, MA |